8-K
Current Report
Viridian Therapeutics, Inc.\DE Filed Acc 0001193125-18-207631
Shareholder vote results
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading d622996d8k.htm…